Leaflet RIFINAH 150mg / 100mg sugar-coated tablets
Indicated for: bacterial infections
Route of administration: oral
Substance: rifampicin + isoniazid (anti-tuberculosis agents)
ATC: J04AM02 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Combinations of drugs for treatment of tuberculosis)
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
Use during pregnancy only on medical advice.
The combination of rifampicin and isoniazid is used for the treatment and prevention of tuberculosis (TB). Rifampicin works by inhibiting bacterial RNA synthesis, while isoniazid interferes with the synthesis of the cell wall of Mycobacterium tuberculosis.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen to prevent the development of bacterial resistance.
Patients should be aware of potential side effects, such as nausea, fatigue, or liver-related symptoms like jaundice. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, fatigue, and liver-related symptoms. In rare cases, severe reactions such as hepatotoxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about RIFINAH 150mg / 100mg
- Substance: rifampicin + isoniazid
- Date of latest medicines list: 01-07-2013
- Product code: W12472001
- Concentration: 150mg / 100mg
- Pharmaceutical form: sugar-coated tablets
- Quantity: 100
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for rifampicin + isoniazid
Concentrations available for rifampicin + isoniazid
- 150mg/100mg
- 300mcg/150mcg
- 300mg/150mg